CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

could we predict the prognosis in high risk gestational trophoblastic disease

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 52
Year: 2019
COI code: DTOGIMED03_177
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors could we predict the prognosis in high risk gestational trophoblastic disease

  Leila Mousavi - assistant profesor, fellowship of gynecology oncology, obstetric and gynecology department, isfahan medical scienceof school, isfahan, iran
Malihe Hasanzadeh Mofrad - profesor, fellowship of gynecology oncology, obstetric and gynecology department, mashhad medical science ofschool, mashhad, iran
Fatemeh Homaie Shandiz - profesor, radio oncology department, mashhad medical science of school, mashhad, iran

Abstract:

Background and Aim : : High risk gestational trophoblastic neoplasia is considered a treatable malignancydue to recent advancements in chemotherapy. This report describes treatment outcomes as a predictor ofprognosis in one instituteMethods : : We performed a retrospective analysis of the treatment results from 41 patients diagnosed withhigh risk and metastatic gestational trophoblastic neoplasia who received treatment at Mashhad Universityof Medical Sciences, Mashhad, Iran from January, 2008 to May, 2014.Results : : Patients had a mean age of 31.31 years. Average treatment time was 3.5 months. Within theparticipants; 19 patients with World Health Organization scores over 7; received methotrexate at the firstline of treatment. 11 cases(26.8%) of the 19 patients with single agent chemotherapy showed resistance.The patients who were resistant to treatment received a combination chemotherapy as the second line oftreatment. The response rate of the etoposide, methotrexate, actinomycin D, cyclophosphamide and oncovinchemotherapy regimen as the first line of treatment was 93.7%, which decreased to approximately 83.3%when administered asthe second line of treatment. There were 76.4% of cases in remission at the one yearfollow-up and a successful pregnancy rate of 17.5%.Astatistically significant relation existed betweenchemotherapy response rate with disease stage, score, site, and number of metastases (P<0.05).Conclusion : TheWorld Health Organization/International Federation of Gynecology and Obstetricsstaging-scoring system is appropriate for gestational trophoblastic neoplasia management. The etoposide,methotrexate, actinomycin D, cyclophosphamide, and oncovin regimen showed superior efficacy. Theimportance of accurate patient selection for adjuvant surgery in high risk gestational trophoblastic neoplasiacannot be emphasized.

Keywords:

Gestational trophoblastic disease, Drug therapy, Prognosis

Perma Link

https://www.civilica.com/Paper-DTOGIMED03-DTOGIMED03_177.html
COI code: DTOGIMED03_177

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Mousavi, Leila; Malihe Hasanzadeh Mofrad & Fatemeh Homaie Shandiz, 2019, could we predict the prognosis in high risk gestational trophoblastic disease, 3rd debatable topics on obstetrics gynecology & infertility, تهران, دانشگاه علوم پزشكي و خدمات بهداشتي و درماني شهيد بهشتي, https://www.civilica.com/Paper-DTOGIMED03-DTOGIMED03_177.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Mousavi, Leila; Malihe Hasanzadeh Mofrad & Fatemeh Homaie Shandiz, 2019)
Second and more: (Mousavi; Hasanzadeh Mofrad & Homaie Shandiz, 2019)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Research Info Management

Export Citation info of this paper to research management softwares

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.